United States · FDA National Drug Code directory
cevimeline hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-3168_0e5763b8-0263-43fa-beaa-7828aa1d5be4
- Product NDC
- 71335-3168
- Form
- CAPSULE
- Composition / generic term
- cevimeline hydrochloride
- Labeler
- Bryant Ranch Prepack
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230103
- Source listing expiry
- 20271231
Source-listed ingredients
- CEVIMELINE HYDROCHLORIDE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (71335-3168-1) · 71335-3168-1
- 60 CAPSULE in 1 BOTTLE (71335-3168-2) · 71335-3168-2
- 90 CAPSULE in 1 BOTTLE (71335-3168-3) · 71335-3168-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →